In this interview, PD Dr Jan Zeidler explains how Biontech arrived at its high price demands and to what extent the new debt is still reasonable. You can find the interview here.
In this interview, PD Dr Jan Zeidler explains how Biontech arrived at its high price demands and to what extent the new debt is still reasonable. You can find the interview here.
Last Change: 06.03.26
